Asia Pacific In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity

August 2022 | 137 pages | ID: A862D95BD025EN
GMD Research

Abstracts

Asia Pacific in vitro diagnostics (IVD) market will grow by 7.8% annually with a total addressable market cap of $303,673.6 million over 2022-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing.

Highlighted with 35 tables and 64 figures, this 138-page report “Asia Pacific In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific in vitro diagnostics (IVD) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific in vitro diagnostics (IVD) market in every aspect of the classification from perspectives of Product, Technology, Sample Type, Application, End User, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Instruments & Devices
• Disposable IVD Devices
• Reusable IVD Devices
• Reagents & Kits
• Software & Services

Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Clinical Chemistry
• Molecular Diagnostics
• Immuno Diagnostics
• Hematology
• Tissue Diagnostics
• Microbiology
• Coagulation and Hemostasis
• Urinalysis
• Other Technologies

By Sample Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Blood
• Mucus
• Urine
• Other Sample Types

By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Infectious Diseases
• Diabetes
• Cancer/Oncology
• Cardiology
• Autoimmune Disease
• Nephrology
• Drug Testing
• HIV/AIDS
• Other Applications

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Diagnostic Laboratories
• Hospitals and Clinics
• Homecare Settings
• Point-of-Care (POC) Settings
• Other End Users

Geographically, the following national/local markets are fully investigated:

• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Application and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abbott Laboratories, Inc.

Agilent Technologies, Inc.

Arkray Inc.

Becton, Dickinson and Company

Biomerieux SA

Bio-Rad Laboratories Inc.

Danaher Corporation

DiaSorin SpA (Luminex Corporation)

Epic Systems Corporation

F. Hoffmann-La Roche Ltd.

Genpact Limited

Grifols SA

IBM Corporation

Mckesson Corporation

Ortho Clinical Diagnostics Inc.

Qiagen NV

Quest Diagnostics Inc.

Quidel Corporation

Roche Diagnostics

Siemens Healthineers

Sysmex Corporation

Thermo Fisher Scientific Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF ASIA PACIFIC MARKET BY PRODUCT

3.1 Market Overview by Product
3.2 Instruments & Devices
  3.2.1 Disposable IVD Devices
  3.2.2 Reusable IVD Devices
3.3 Reagents & Kits
3.4 Software & Services

4 SEGMENTATION OF ASIA PACIFIC MARKET BY TECHNOLOGY

4.1 Market Overview by Technology
4.2 Clinical Chemistry
4.3 Molecular Diagnostics
4.4 Immuno Diagnostics
4.5 Hematology
4.6 Tissue Diagnostics
4.7 Microbiology
4.8 Coagulation and Hemostasis
4.9 Urinalysis
4.10 Other Technologies

5 SEGMENTATION OF ASIA PACIFIC MARKET BY SAMPLE TYPE

5.1 Market Overview by Sample Type
5.2 Blood
5.3 Mucus
5.4 Urine
5.5 Other Sample Types

6 SEGMENTATION OF ASIA PACIFIC MARKET BY APPLICATION

6.1 Market Overview by Application
6.2 Infectious Diseases
6.3 Diabetes
6.4 Cancer/Oncology
6.5 Cardiology
6.6 Autoimmune Disease
6.7 Nephrology
6.8 Drug Testing
6.9 HIV/AIDS
6.10 Other Applications

7 SEGMENTATION OF ASIA PACIFIC MARKET BY END USER

7.1 Market Overview by End User
7.2 Diagnostic Laboratories
7.3 Hospitals and Clinics
7.4 Homecare Settings
7.5 Point-of-Care (POC) Settings
7.6 Other End Users

8 ASIA-PACIFIC MARKET 2021-2031 BY COUNTRY

8.1 Overview of Asia-Pacific Market
8.2 Japan
8.3 China
8.4 Australia
8.5 India
8.6 South Korea
8.7 Rest of APAC Region

9 COMPETITIVE LANDSCAPE

9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Arkray Inc.
Becton, Dickinson and Company
Biomerieux SA
Bio-Rad Laboratories Inc.
Danaher Corporation
DiaSorin SpA (Luminex Corporation)
Epic Systems Corporation
F. Hoffmann-La Roche Ltd.
Genpact Limited
Grifols SA
IBM Corporation
Mckesson Corporation
Ortho Clinical Diagnostics Inc.
Qiagen NV
Quest Diagnostics Inc.
Quidel Corporation
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific Inc.
RELATED REPORTS

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of Asia Pacific In Vitro Diagnostics Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Main Product Trends and Market Opportunities in Asia Pacific In Vitro Diagnostics Market
Table 6. Asia Pacific In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 7. Asia Pacific In Vitro Diagnostics Market: Instruments & Devices by Type, 2021-2031, $ mn
Table 8. Asia Pacific In Vitro Diagnostics Market by Technology, 2021-2031, $ mn
Table 9. Asia Pacific In Vitro Diagnostics Market by Sample Type, 2021-2031, $ mn
Table 10. Asia Pacific In Vitro Diagnostics Market by Application, 2021-2031, $ mn
Table 11. Commercially Available COVID-19 Diagnostic Tests Approved in 2021-2022
Table 12. Asia Pacific In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 13. APAC In Vitro Diagnostics Market by Country, 2021-2031, $ mn
Table 14. Japan In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 15. Japan In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 16. Japan In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 17. China In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 18. China In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 19. China In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 20. Australia In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 21. Australia In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 22. Australia In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 23. India In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 24. India In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 25. India In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 26. South Korea In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 27. South Korea In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 28. South Korea In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 29. In Vitro Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 30. Abbott Laboratories, Inc.: Company Snapshot
Table 31. Abbott Laboratories, Inc.: Business Segmentation
Table 32. Abbott Laboratories, Inc.: Product Portfolio

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Asia Pacific In Vitro Diagnostics Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Asia Pacific In Vitro Diagnostics Market
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060
Figure 10. Primary Restraints and Impact Factors of Asia Pacific In Vitro Diagnostics Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific In Vitro Diagnostics Market
Figure 13. Breakdown of Asia Pacific In Vitro Diagnostics Market by Product, 2021-2031, % of Revenue
Figure 14. Asia Pacific Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%)
Figure 15. Asia Pacific In Vitro Diagnostics Market by Product: Instruments & Devices, 2021-2031, $ mn
Figure 16. Asia Pacific In Vitro Diagnostics Market by Instruments & Devices: Disposable IVD Devices, 2021-2031, $ mn
Figure 17. Asia Pacific In Vitro Diagnostics Market by Instruments & Devices: Reusable IVD Devices, 2021-2031, $ mn
Figure 18. Asia Pacific In Vitro Diagnostics Market by Product: Reagents & Kits, 2021-2031, $ mn
Figure 19. Asia Pacific In Vitro Diagnostics Market by Product: Software & Services, 2021-2031, $ mn
Figure 20. Breakdown of Asia Pacific In Vitro Diagnostics Market by Technology, 2021-2031, % of Sales Revenue
Figure 21. Asia Pacific Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%)
Figure 22. Asia Pacific In Vitro Diagnostics Market by Technology: Clinical Chemistry, 2021-2031, $ mn
Figure 23. Asia Pacific In Vitro Diagnostics Market by Technology: Molecular Diagnostics, 2021-2031, $ mn
Figure 24. Asia Pacific In Vitro Diagnostics Market by Technology: Immuno Diagnostics, 2021-2031, $ mn
Figure 25. Asia Pacific In Vitro Diagnostics Market by Technology: Hematology, 2021-2031, $ mn
Figure 26. Asia Pacific In Vitro Diagnostics Market by Technology: Tissue Diagnostics, 2021-2031, $ mn
Figure 27. Asia Pacific In Vitro Diagnostics Market by Technology: Microbiology, 2021-2031, $ mn
Figure 28. Asia Pacific In Vitro Diagnostics Market by Technology: Coagulation and Hemostasis, 2021-2031, $ mn
Figure 29. Asia Pacific In Vitro Diagnostics Market by Technology: Urinalysis, 2021-2031, $ mn
Figure 30. Asia Pacific In Vitro Diagnostics Market by Technology: Other Technologies, 2021-2031, $ mn
Figure 31. Breakdown of Asia Pacific In Vitro Diagnostics Market by Sample Type, 2021-2031, % of Sales Revenue
Figure 32. Asia Pacific Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%)
Figure 33. Asia Pacific In Vitro Diagnostics Market by Sample Type: Blood, 2021-2031, $ mn
Figure 34. Asia Pacific In Vitro Diagnostics Market by Sample Type: Mucus, 2021-2031, $ mn
Figure 35. Asia Pacific In Vitro Diagnostics Market by Sample Type: Urine, 2021-2031, $ mn
Figure 36. Asia Pacific In Vitro Diagnostics Market by Sample Type: Other Sample Types, 2021-2031, $ mn
Figure 37. Breakdown of Asia Pacific In Vitro Diagnostics Market by Application, 2021-2031, % of Revenue
Figure 38. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 39. Asia Pacific In Vitro Diagnostics Market by Application: Infectious Diseases, 2021-2031, $ mn
Figure 40. Asia Pacific In Vitro Diagnostics Market by Application: Diabetes, 2021-2031, $ mn
Figure 41. Asia Pacific In Vitro Diagnostics Market by Application: Cancer/Oncology, 2021-2031, $ mn
Figure 42. Asia Pacific In Vitro Diagnostics Market by Application: Cardiology, 2021-2031, $ mn
Figure 43. Asia Pacific In Vitro Diagnostics Market by Application: Autoimmune Disease, 2021-2031, $ mn
Figure 44. Asia Pacific In Vitro Diagnostics Market by Application: Nephrology, 2021-2031, $ mn
Figure 45. Asia Pacific In Vitro Diagnostics Market by Application: Drug Testing, 2021-2031, $ mn
Figure 46. Asia Pacific In Vitro Diagnostics Market by Application: HIV/AIDS, 2021-2031, $ mn
Figure 47. Asia Pacific In Vitro Diagnostics Market by Application: Other Applications, 2021-2031, $ mn
Figure 48. Breakdown of Asia Pacific In Vitro Diagnostics Market by End User, 2021-2031, % of Revenue
Figure 49. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 50. Asia Pacific In Vitro Diagnostics Market by End User: Diagnostic Laboratories, 2021-2031, $ mn
Figure 51. Asia Pacific In Vitro Diagnostics Market by End User: Hospitals and Clinics, 2021-2031, $ mn
Figure 52. Asia Pacific In Vitro Diagnostics Market by End User: Homecare Settings, 2021-2031, $ mn
Figure 53. Asia Pacific In Vitro Diagnostics Market by End User: Point-of-Care (POC) Settings, 2021-2031, $ mn
Figure 54. Asia Pacific In Vitro Diagnostics Market by End User: Other End Users, 2021-2031, $ mn
Figure 55. Breakdown of APAC In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 56. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 57. In Vitro Diagnostics Market in Japan, 2021-2031, $ mn
Figure 58. In Vitro Diagnostics Market in China, 2021-2031, $ mn
Figure 59. In Vitro Diagnostics Market in Australia, 2021-2031, $ mn
Figure 60. In Vitro Diagnostics Market in India, 2021-2031, $ mn
Figure 61. In Vitro Diagnostics Market in South Korea, 2021-2031, $ mn
Figure 62. In Vitro Diagnostics Market in Rest of APAC, 2021-2031, $ mn
Figure 63. Growth Stage of Asia Pacific In Vitro Diagnostics Industry over the Forecast Period